Highlights
- •Millions in the United States struggle to afford their prescribed insulin.
- •Recent legislation provides insulin price capping only for Medicare recipients
- •No current legislation provides relief for those with private insurance or who are uninsured.
- •Nurse practitioners are in a unique position to help shape public health policy.
- •Nurse practitioners should feel empowered to contact their representatives and advocate for their patients by supporting insulin price capping.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The Journal for Nurse PractitionersAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Biography
Lindsay Appleton, MSN, AGACNP-BC, RN-BC, CEN, is a nurse practitioner practicing in Charlotte, NC. She can be contacted at [email protected]
Article info
Publication history
Published online: December 06, 2022
Publication stage
In Press Corrected ProofFootnotes
In compliance with standard ethical guidelines, the author reports no relationships with business or industry that may pose a conflict of interest.
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
